TNFRSF9 and idiopathic pulmonary fibrosis: Strengths of this study include replication in two well-characterized cohorts of smokers, cross-technology replication (both RNA-seq and microarray), and the application of causal inference analyses to examine the relationship between IPF and ILA transcriptomic risk with aging and risk of death.